← Eichor
Condition: Meningioma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Meningioma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
NA · 1 location(s) · Dartmouth-Hitchcock Medical Center · NCT06930846Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
Phase N/A · 1 location(s) · Mohamed Abdel-Rahman · NCT04792463Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely
Phase 3 · 215 location(s) · NRG Oncology · NCT03180268Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults
NA · 1 location(s) · Beijing Sanbo Brain Hospital · NCT04501705177Lu-DOTATATE for Recurrent Meningioma
Phase 2 · 19 location(s) · European Organisation for Research and Treatment of Cancer - · NCT06326190TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT06640582NEO100 and High-Grade Meningioma
Phase 2 · 5 location(s) · Neonc Technologies, Inc. · NCT05023018Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Phase 2 · 780 location(s) · Alliance for Clinical Trials in Oncology · NCT02523014Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Phase 1 · 1 location(s) · Jazz Pharmaceuticals · NCT04541082NK Cell Therapy for Malignant Solid Brain Tumors
NA · 4 location(s) · Peking University Third Hospital · NCT07552233Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treat
Phase 1/Phase 2 · 1 location(s) · Fundación de investigación HM · NCT06607692Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
Phase 1/Phase 2 · 19 location(s) · Perspective Therapeutics · NCT05636618Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma
Phase 1 · 1 location(s) · Javier Villaneuva-Meyer, MD · NCT06014905Combination of Everolimus and 177Lu-DOTATATE in the Treatment of Grades 2 and 3 Refractory Meningioma: a Phase IIb Clini
Phase 2 · 2 location(s) · Central Hospital, Nancy, France · NCT06126588Regorafenib for Recurrent Meningioma (MIRAGE Trial)
Phase 2 · 17 location(s) · Istituto Oncologico Veneto IRCCS · NCT06275919Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Phase N/A · 54 location(s) · GT Medical Technologies, Inc. · NCT04427384Embolization for Meningioma
NA · 1 location(s) · St. Olavs Hospital · NCT05416567Neurocognitive Impact of Different Irradiation Modalities for Patients With Grade I-II Skull Base Meningioma:
NA · 3 location(s) · Centre Francois Baclesse · NCT06036706Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema
Phase 2 · 1 location(s) · Peter Siesjö · NCT06710249Abemaciclib in Newly Diagnosed Meningioma Patients
Phase 2 · 1 location(s) · Nader Sanai · NCT05940493Cognitive Status After Removal of Skull Base Meningioma
Phase N/A · 1 location(s) · Ohio State University · NCT04635657Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3
Phase 2 · 8 location(s) · Northwestern University · NCT02847559Cabozantinib for Patients With Recurrent or Progressive Meningioma
Phase 2 · 3 location(s) · Baptist Health South Florida · NCT05425004Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transde
NA · 1 location(s) · Medical University of Warsaw · NCT07413796Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotide
Phase 1/Phase 2 · 1 location(s) · University Hospital, Basel, Switzerland · NCT04997317Predictive Factors for Survival in Aggressive Meningiomas
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05793034Natural History Study of Patients With Neurofibromatosis Type 2
Phase N/A · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT00598351Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE
Phase 4 · 1 location(s) · Weill Medical College of Cornell University · NCT06377371Search for Circulating Tumour Cells in the Blood and/or Cerebrospinal Fluid in Patients With Recurrent Aggressive Mening
NA · 1 location(s) · University Hospital, Montpellier · NCT07398170Translation and Validation of the MQOL Self-questionnaire Into French for Assessing Quality of Life in Patients With Men
Phase N/A · 1 location(s) · Centre Hospitalier St Anne · NCT07044076
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.